Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0031 | 0.021 | 0.021 |
Loa Loa (eye worm) | vesicular acetylcholine transporter unc-17 | 0.072 | 1 | 1 |
Brugia malayi | RNA binding protein | 0.0125 | 0.1543 | 0.1543 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0031 | 0.021 | 0.021 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0099 | 0.1175 | 0.1175 |
Echinococcus granulosus | vesicular acetylcholine transporter | 0.072 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.021 | 0.021 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0031 | 0.021 | 0.021 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0095 | 0.1121 | 0.1121 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0038 | 0.0308 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0031 | 0.021 | 0.021 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.1543 | 0.1543 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0095 | 0.1121 | 0.1121 |
Brugia malayi | MH2 domain containing protein | 0.0244 | 0.3237 | 0.3237 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0042 | 0.0357 | 0.0357 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0095 | 0.1121 | 0.1121 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0038 | 0.0308 | 0.5 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0042 | 0.0357 | 0.5 |
Schistosoma mansoni | vesicular acetylcholine transporter | 0.072 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0095 | 0.1121 | 0.1121 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0031 | 0.021 | 0.021 |
Brugia malayi | Probable ClpP-like protease | 0.0077 | 0.0853 | 0.0853 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.1543 | 0.1543 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0077 | 0.0853 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0142 | 0.1784 | 0.1784 |
Onchocerca volvulus | Vesicular acetylcholine transporter homolog | 0.072 | 1 | 0.5 |
Echinococcus multilocularis | vesicular acetylcholine transporter | 0.072 | 1 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0042 | 0.0357 | 0.3059 |
Echinococcus granulosus | peptidase Clp S14 family | 0.005 | 0.0478 | 0.0478 |
Brugia malayi | TAR-binding protein | 0.0125 | 0.1543 | 0.1543 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.021 | 0.021 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0042 | 0.0357 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0031 | 0.021 | 0.021 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.0728 | 0.0728 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0125 | 0.1543 | 0.1543 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0095 | 0.1121 | 0.1121 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.1543 | 0.1543 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.1543 | 0.1543 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0138 | 0.1727 | 0.1727 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.1121 | 0.1121 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0077 | 0.0853 | 0.0853 |
Echinococcus multilocularis | tar DNA binding protein | 0.0125 | 0.1543 | 0.1543 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.1121 | 0.1121 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0068 | 0.0728 | 0.0728 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0042 | 0.0357 | 0.3059 |
Loa Loa (eye worm) | TAR-binding protein | 0.0125 | 0.1543 | 0.1543 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 0.0853 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0077 | 0.0853 | 1 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0038 | 0.0308 | 0.2366 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 0.5 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0244 | 0.3237 | 0.3237 |
Echinococcus multilocularis | GPCR, family 2 | 0.0031 | 0.021 | 0.021 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 2 ClpP2 (endopeptidase CLP 2) | 0.005 | 0.0478 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0125 | 0.1543 | 0.1543 |
Schistosoma mansoni | tar DNA-binding protein | 0.0125 | 0.1543 | 0.1543 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0125 | 0.1543 | 0.1543 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.005 | 0.0478 | 0.0478 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0125 | 0.1543 | 0.1543 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 0.5 |
Loa Loa (eye worm) | acetyltransferase | 0.0142 | 0.1784 | 0.1784 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0099 | 0.1175 | 0.1175 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0031 | 0.021 | 0.021 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0099 | 0.1175 | 0.1175 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0142 | 0.1784 | 0.1784 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 CLPP1 (ENDOPEPTIDASE CLP) | 0.005 | 0.0478 | 0.4744 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0244 | 0.3237 | 0.3237 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 0.0853 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.1175 | 0.1175 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0077 | 0.0853 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.0853 | 0.0853 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.021 | 0.021 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.1121 | 0.1121 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.021 | 0.021 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0031 | 0.021 | 0.021 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0031 | 0.021 | 0.021 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0142 | 0.1784 | 0.1784 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.0728 | 0.0728 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0095 | 0.1121 | 0.1121 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0042 | 0.0357 | 0.3059 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0077 | 0.0853 | 1 |
Mycobacterium tuberculosis | Probable ATP-dependent CLP protease proteolytic subunit 1 ClpP1 (endopeptidase CLP) | 0.005 | 0.0478 | 0.5 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0077 | 0.0853 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.